Myofibroblast - like cells and liver fibrogenesis: Emerging concepts in a rapidly moving scenario.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Molecular Aspects of Medicine

• Publication date

  2008-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.MAM.2007.09.002PMID 18022682
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sinusoidal remodeling and angiogenesis: A new function for the liver‐specific pericyte?

  2007cited by this paper
• Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: engraftment and hepatocyte differentiation versus profibrogenic potential

  2007cited by this paper
• Biliary epithelial‐mesenchymal transition in posttransplantation recurrence of primary biliary cirrhosis

  2007cited by this paper
• Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ.

  2007cited by this paper
• Proangiogenic cytokines as hypoxia-dependent factors stimulating migration of human hepatic stellate cells.

  2007cited by this paper
• NADPH oxidase in the liver: defensive, offensive, or fibrogenic?

  2006cited by this paper
• Nonalcoholic fatty liver disease: Cytokine-adipokine interplay and regulation of insulin resistance.

  2006cited by this paper
• Oxidative‐stress and IL‐6 mediate the fibrogenic effects of rodent Kupffer cells on stellate cells

  2006cited by this paper
• Reversal of hepatic fibrosis — Fact or fantasy?

  2006cited by this paper
• The bone marrow functionally contributes to liver fibrosis.

  2006cited by this paper
• Early N400 development and later language acquisition.

  2006cited by this paper
• Alcohol, oxidative stress and free radical damage

  2006cited by this paper
• Mechanisms of alcohol‐induced hepatic fibrosis: A summary of the Ron Thurman Symposium

  2006cited by this paper
• Bone marrow stem cells and liver disease

  2006cited by this paper
• Resistin as an intrahepatic cytokine: overexpression during chronic injury and induction of proinflammatory actions in hepatic stellate cells.

  2006cited by this paper
• Liver Diseases (2 Vols.) : Biochemical Mechanisms and New Therapeutic Insights

  2006cited by this paper
• Phagocytosis of apoptotic bodies by hepatic stellate cells induces NADPH oxidase and is associated with liver fibrosis in vivo

  2006cited by this paper
• Liver fibrosis.

  2005cited by this paper
• The roles of leptin and adiponectin: a novel paradigm in adipocytokine regulation of liver fibrosis and stellate cell biology.

  2005cited by this paper
• Nonalcoholic fatty liver disease

  2005cited by this paper
• Dose dependent and divergent effects of superoxide anion on cell death, proliferation, and migration of activated human hepatic stellate cells

  2005cited by this paper
• Immune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosis

  2005cited by this paper
• Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells

  2005cited by this paper
• The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis

  2005cited by this paper
• Evidence of angiogenesis in primary biliary cirrhosis: an immunohistochemical descriptive study.

  2005cited by this paper
• Overexpression of Bcl-2 by activated human hepatic stellate cells: resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans

  2005cited by this paper
• Oxidative stress as a trigger for cellular immune responses in patients with alcoholic liver disease

  2004cited by this paper
• Liver fibrosis

  2004cited by this paper
• 4-Hydroxynonenal as a selective pro-fibrogenic stimulus for activated human hepatic stellate cells.

  2004cited by this paper
• Mechanisms of Disease: mechanisms of hepatic fibrosis and therapeutic implications

  2004cited by this paper
• Cirrhosis reversal: a duel between dogma and myth.

  2004cited by this paper
• Liver fibrosis: from the bench to clinical targets.

  2004cited by this paper
• CONCISE REVIEW IN MECHANISMS OF DISEASE Angiogenesis in Chronic Inflammatory Liver Disease

  2004cited by this paper
• Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin.

  2004cited by this paper
• The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice.

  2003cited by this paper
• Liver fibrosis -- from bench to bedside.

  2003cited by this paper
• NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis.

  2003cited by this paper
• Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis

  2003cited by this paper
• Angiogenesis in health and disease

  2003cited by this paper
• Alcohol, Oxidative Stress, and Free Radical Damage

  2003cited by this paper
• Hepatocyte growth factor activates endothelial proangiogenic mechanisms relevant in chronic hepatitis C-associated neoangiogenesis.

  2003cited by this paper
• Gliotoxin-mediated apoptosis of activated human hepatic stellate cells.

  2003cited by this paper
• Hypoxia‐induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis

  2002cited by this paper
• Free radicals in the physiological control of cell function.

  2002cited by this paper
• Beauty is in the eye of the beholder: emerging concepts and pitfalls in hepatic stellate cell research.

  2002cited by this paper
• Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C.

  2002cited by this paper
• Nonalcoholic fatty liver disease.

  2002cited by this paper
• Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C.

  2002cited by this paper
• Leptin augments inflammatory and profibrogenic responses in the murine liver induced by hepatotoxic chemicals

  2001cited by this paper
• Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers.

  2001cited by this paper
• Cytokine Receptors and Signaling in Hepatic Stellate Cells

  2001cited by this paper
• Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct.

  2001cited by this paper
• Progression of fibrosis in chronic liver diseases: time to tally the score.

  2001cited by this paper
• Oxidative stress-related molecules and liver fibrosis.

  2001cited by this paper
• 15-deoxy-Delta 12,14-prostaglandin J2 induces apoptosis of human hepatic myofibroblasts. A pathway involving oxidative stress independently of peroxisome-proliferator-activated receptors.

  2001cited by this paper
• Molecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue Injury*

  2000cited by this paper
• Interaction between 4-hydroxy-2,3-alkenals and the platelet-derived growth factor-beta receptor. Reduced tyrosine phosphorylation and downstream signaling in hepatic stellate cells.

  2000cited by this paper
• Regression of human cirrhosis. Morphologic features and the genesis of incomplete septal cirrhosis.

  2000cited by this paper
• Ductular reaction and its diagnostic significance.

  1998cited by this paper
• Coordinated induction of VEGF receptors in mesenchymal cell types during rat hepatic wound healing

  1998cited by this paper
• HNE interacts directly with JNK isoforms in human hepatic stellate cells.

  1998cited by this paper
• Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups.

  1997cited by this paper
• Reversibility of Hepatic Fibrosis in Autoimmune Hepatitis

  1997cited by this paper

• The role of tetraspanins in organ fibrosis: mechanisms and therapeutic perspectives

  2025cites this paper
• Single cell multiomics reveals drivers of metabolic dysfunction-associated steatohepatitis

  2025cites this paper
• Assessment of hypoxia status in a rat chronic liver disease model using IVIM and T1 mapping

  2025cites this paper
• Regulation of Hepatic Stellate Cell Phenotypes in MASH.

  2025cites this paper
• Alcohol-Associated Liver Disease Outcomes: Critical Mechanisms of Liver Injury Progression

  2024cites this paper
• Anti-Angiogenic Effects of Natural Compounds in Diet-Associated Hepatic Inflammation

  2023cites this paper
• An inducible model for genetic manipulation and fate-tracing of PDGFRβ-expressing fibrogenic cells in the liver

  2023cites this paper
• Invited review liver fibrosis in NAFLD/NASH: From pathophysiology towards diagnostic and therapeutic strategies.

  2023cites this paper
• The Origin and Fate of Liver Myofibroblasts

  2023cites this paper
• Efficacy and potential mechanisms of the main active ingredients of astragalus mongholicus in animal models of liver fibrosis: A systematic review and meta-analysis.

  2023cites this paper
• Unfolded Protein Response Signaling in Hepatic Stem Cell Activation in Liver Fibrosis.

  2023cites this paper
• Dietary sources, health benefits, and risks of caffeine

  2022cites this paper
• Correlation between serum laminin levels and prognosis of acute myocardial infarction

  2022cites this paper
• Sorafenib-loaded silica-containing redox nanoparticles for oral anti-liver fibrosis therapy.

  2022cites this paper
• Hepatic Myofibroblasts: A Heterogeneous and Redox-Modulated Cell Population in Liver Fibrogenesis

  2022cites this paper
• Combination therapy based on targeted nano drug co-delivery systems for liver fibrosis treatment: a review

  2022cites this paper
• Hypoxia, Hypoxia-Inducible Factors and Liver Fibrosis

  2021cites this paper
• Macrophage Activation Markers, Soluble CD163 and Mannose Receptor, in Liver Fibrosis

  2021cites this paper
• Cytoplasmic vacuolation with endoplasmic reticulum stress directs sorafenib induced non-apoptotic cell death in hepatic stellate cells

  2021cites this paper
• Liver failure—future challenges and remaining questions

  2021cites this paper
• Liver Stiffness and Acute Liver Failure

  2020cites this paper
• Angiogenesis in the progression from liver fibrosis to cirrhosis and hepatocelluar carcinoma

  2020cites this paper
• Platycodin D alleviates liver fibrosis and activation of hepatic stellate cells by regulating JNK/c-JUN signal pathway.

  2020cites this paper
• Hepatic stellate cell: A potential target for hepatocellular carcinoma.

  2020cites this paper
• Mechanisms of Fibrogenesis in NASH

  2020cites this paper
• Evolving therapies for Peyronie’s disease: how can we work towards new drugs?

  2020cites this paper
• Elucidating Potential Profibrotic Mechanisms of Emerging Biomarkers for Early Prognosis of Hepatic Fibrosis

  2020cites this paper
• Liver fibrogenesis: UN update on established and emerging basic concepts.

  2020cites this paper
• Non-Alcoholic Fatty Liver Disease: A 360-degree Overview

  2020cites this paper
• Crosstalk Between Angiogenesis and Fibrogenesis in Liver Disease

  2020cites this paper
• What role do pharmaceuticals play in the treatment of Peyronie’s disease and is there a need for new emerging drugs?

  2019cites this paper
• Autoimmune Hepatitis and Stellate Cells; an Insight into the Role of Autophagy.

  2019cites this paper
• Pathophysiology and Future Therapeutic Perspectives for Resolving Fibrosis in Peyronie's Disease.

  2019cites this paper
• Bone marrow-derived mesenchymal stem cells utilize the notch signaling pathway to induce apoptosis of hepatic stellate cells via NF-κB sensor

  2019cites this paper
• EVALUATION OF THE POSSIBLE CURATIVE EFFECT OF NIGELLA SATIVA LINN OIL ON EXPERIMENTALLY ACETAMINOPHEN-INDUCED HEPATOTOXICITY AND NEPHROTOXICITY IN ADULT MALE ALBINO RATS

  2019cites this paper
• Oncostatin M, A Profibrogenic Mediator Overexpressed in Non-Alcoholic Fatty Liver Disease, Stimulates Migration of Hepatic Myofibroblasts

  2019cites this paper
• Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues.

  2019influential citation
• Blockade of YAP alleviates hepatic fibrosis through accelerating apoptosis and reversion of activated hepatic stellate cells

  2019cites this paper
• Effect of Curcumin and Gliotoxin on Rat Liver Myofibroblast Culture

  2018cites this paper
• Inhibition effect of phytoestrogen calycosin on TGF-β1-induced hepatic stellate cell activation, proliferation, and migration via estrogen receptor β.

  2018cites this paper
• Carvedilol attenuates liver fibrosis by suppressing autophagy and promoting apoptosis in hepatic stellate cells.

  2018cites this paper
• Abrogation of ALK5 in hepatic stellate cells decreases hepatic fibrosis and ameliorates liver damage in mice following treatment with thioacetamide

  2018cites this paper
• The mechanisms and potential of stem cell therapy for penile fibrosis

  2018cites this paper
• 5 – The Liver's Response to Injury: Inflammation and Fibrosis

  2018cites this paper
• Pathophysiology of liver fibrosis and the methodological barriers to the development of anti-fibrogenic agents.

  2017cites this paper
• Cell Therapy in Chronic Liver Disease

  2017cites this paper
• Protective effect of dehydroandrographolide on obstructive cholestasis in bile duct-ligated mice

  2017cites this paper
• Autophagy mediated by endoplasmic reticulum stress enhances the caffeine-induced apoptosis of hepatic stellate cells

  2017cites this paper
• Noninvasive Diagnostic and Prognostic Assessment Tools for Liver Fibrosis and Cirrhosis in Patients with Chronic Liver Disease

  2017cites this paper
• A comparative study on the anti-schistosomal and hepatoprotective effects of vinpocetine and isosorbide-5-mononitrate on Schistosoma mansoni-infected mice.

  2017cites this paper
• Investigating immunological and metabolic pathways involved in the pathogenesis of chronic liver disease

  2017cites this paper
• Pathogenesis of biliary fibrosis.

  2017cites this paper
• Human hepatic stellate cell isolation and characterization

  2017cites this paper
• Therapeutic pro-fibrogenic signaling pathways in fibroblasts.

  2017influential citation
• Protective effects of Ampelopsis brevipedunculata against in vitro hepatic stellate cells system and thioacetamide-induced liver fibrosis rat model

  2017cites this paper
• Effect of Curcumin and Gliotoxin on Rat Liver Myofibroblast Culture

  2017cites this paper
• SerpinB3 Promotes Pro-fibrogenic Responses in Activated Hepatic Stellate Cells

  2017cites this paper
• New Concepts on Pathogenesis and Diagnosis of Liver Fibrosis; A Review Article

  2016cites this paper
• Silymarin-loaded Eudragit(®) RS100 nanoparticles improved the ability of silymarin to resolve hepatic fibrosis in bile duct ligated rats.

  2016cites this paper
• Dual-Functional Nanoparticles Targeting CXCR4 and Delivering Antiangiogenic siRNA Ameliorate Liver Fibrosis.

  2016cites this paper
• Development and characterization of sorafenib-loaded PLGA nanoparticles for the systemic treatment of liver fibrosis.

  2016cites this paper
• Fibroblast growth factor 21 attenuates hepatic fibrogenesis through TGF-β/smad2/3 and NF-κB signaling pathways.

  2016cites this paper
• CAN THE MESENCHYMAL STEM CELLS ATTENUATE APOPTOSIS IN ADULT MALE ALBINO RATS WITH ACETAMINOPHEN-INCUCED HEPATIC FAILURE

  2016cites this paper
• Cellular Mechanisms of Tissue Fibrosis Role of Smad 3 in platelet-derived growth factor-C-induced liver fibrosis

  2016cites this paper
• Revisiting Epithelial-to-Mesenchymal Transition in Liver Fibrosis: Clues for a Better Understanding of the “Reactive” Biliary Epithelial Phenotype

  2016cites this paper
• Role of Smad3 in platelet-derived growth factor-C-induced liver fibrosis.

  2016cites this paper
• Hepatocyte-Specific Ablation of PP2A Catalytic Subunit α Attenuates Liver Fibrosis Progression via TGF-β1/Smad Signaling

  2015cites this paper
• Angiogenesis and liver fibrosis.

  2015cites this paper
• Hepatocyte Growth Factor Mediates the Antifibrogenic Action of Ocimum bacilicum Essential Oil against CCl4-Induced Liver Fibrosis in Rats

  2015cites this paper
• Role of Albumin in Hepatic Stellate Cell Activation The Antifibrotic Effects of Albumin

  2015cites this paper
• Hepatic myofibroblasts and fibrogenic progression of chronic liver diseases.

  2015influential citation
• UNIVERSIDADE FEDERAL DO ESPIRITO SANTO CENTRO DE CIÊNCIAS ÁGRARIAS PROGRAMA DE PÓS-GRADUAÇÃO EM CIÊNCIAS VETERINÁRIAS

  2015cites this paper
• Oxidative Stress and Liver Fibrogenesis

  2015cites this paper
• Angiogenesis and Fibrogenesis in Chronic Liver Diseases

  2015cites this paper
• Anti-fibrotic effect of PF2401-SF, a standardized fraction of Salvia miltiorrhiza, in thioacetamide-induced experimental rats liver fibrosis

  2015cites this paper
• Soluble CD146, a novel endothelial marker, is related to the severity of liver disease

  2015cites this paper
• microRNA-21 mediates epithelial-mesenchymal transition of human hepatocytes via PTEN/Akt pathway.

  2015cites this paper
• YAP and TAZ are Mechanoregulators of TGF-β-Smad Signalling and Fibrogenesis

  2015cites this paper
• Bone marrow-derived fibrocytes contribute to liver fibrosis

  2015cites this paper
• Effect of nuclear factor-κB and angiotensin II receptor type 1 on the pathogenesis of rat non-alcoholic fatty liver disease.

  2015cites this paper
• Endothelial biomarker soluble CD146 suggests that angiogenesis plays an important role in progression of fibrosis in liver disease

  2015cites this paper
• Hepatoprotective effect of oral application of a silymarin extract in carbon tetrachloride-induced hepatotoxicity in rats

  2015cites this paper
• Potent effects of dioscin against liver fibrosis

  2015cites this paper
• Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update.

  2014cites this paper
• EMT in Liver Fibrosis

  2014cites this paper
• Inhibition of Tyrosine Kinase Receptor Tie2 Reverts HCV-Induced Hepatic Stellate Cell Activation

  2014cites this paper
• Adult Liver Stem Cells

  2014cites this paper
• Hypoxia, hypoxia-inducible factors and fibrogenesis in chronic liver diseases.

  2014influential citation
• Hepatic stellate cells and extracellular matrix in hepatocellular carcinoma: more complicated than ever

  2014cites this paper
• Catalase ameliorates hepatic fibrosis by inhibition of hepatic stellate cells activation.

  2014cites this paper
• Immunohistochemical evidence for myofibroblast-like cells associated with liver injury induced by aflatoxin B1 in rainbow trout (Oncorhynchus mykiss).

  2014cites this paper
• The types of hepatic myofibroblasts contributing to liver fibrosis of different etiologies

  2014cites this paper
• New Insights in the Roadmap of Liver Fibrosis Pathogenesis

  2014cites this paper
• The tyrosine phosphatase SHP-1 inhibits proliferation of activated hepatic stellate cells by impairing PDGF receptor signaling.

  2014cites this paper
• THE HEPATOPROTECTIVE EFFECT OF NITRIC OXIDE ON MURINE SCHISTOSOMIASIS MANSONI

  2014cites this paper
• Myofibroblasts in Normal and Fibrotic Liver in Different Animal Species

  2014cites this paper
• Cellular and molecular mechanisms in liver fibrogenesis.

  2014cites this paper
• Strategies to Detect Hepatic Myofibroblasts in Liver Cirrhosis of Different Etiologies

  2014cites this paper
• Lobe-Specific Heterogeneity in Asymmetric Dimethylarginine and Matrix Metalloproteinase Levels in a Rat Model of Obstructive Cholestasis

  2014cites this paper
• Chronic restraint stress decreases the repair potential from mesenchymal stem cells on liver injury by inhibiting TGF-β1 generation

  2014cites this paper